PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset

Active filters

  • Chemical substance: Heparinoid
Presentation Product Chemical substance Chapter Items dispensed
Movelat gel
1003020W0BBABAA
Movelat Heparinoid Musculoskeletal and Joint Diseases 24,593
Heparinoid 0.3% cream
1314000H0AAAAAA
Heparinoid (Topical circulatory preparations) Heparinoid Skin 11,430
Salicylic acid 2% / Mucopolysaccharide polysulfate 0.2% gel
1003020W0AAAAAA
Heparinoid (Topical Antirheumatic) Heparinoid Musculoskeletal and Joint Diseases 10,422
Movelat cream
1003020W0BBAAAB
Movelat Heparinoid Musculoskeletal and Joint Diseases 8,885
Heparinoid 0.3% gel
1314000H0AAABAB
Heparinoid (Topical circulatory preparations) Heparinoid Skin 5,863
Hirudoid 0.3% cream
1314000H0BBAAAA
Hirudoid Heparinoid Skin 4,687
Hirudoid 0.3% gel
1314000H0BBABAB
Hirudoid Heparinoid Skin 3,293
Salicylic acid 2% / Mucopolysaccharide polysulfate 0.2% crm
1003020W0AAABAB
Heparinoid (Topical Antirheumatic) Heparinoid Musculoskeletal and Joint Diseases 2,647
Movelat Relief gel
1003020W0BBADAA
Movelat Heparinoid Musculoskeletal and Joint Diseases 966
Movelat Relief cream
1003020W0BBACAB
Movelat Heparinoid Musculoskeletal and Joint Diseases 528
Anacal rectal ointment
0107010J0BBABAB
Anacal Heparinoid Gastro-Intestinal System No data available
Anacal suppositories
0107010J0BBAAAA
Anacal Heparinoid Gastro-Intestinal System No data available
Bruiseze 0.8% ointment
1314000H0BDAAAC
Bruiseze Heparinoid Skin No data available
Heparinoid 0.8% ointment
1314000H0AAACAC
Heparinoid (Topical circulatory preparations) Heparinoid Skin No data available
Lasonil 0.8% ointment
1314000H0BCAAAC
Lasonil Heparinoid Skin No data available
Lauromacrogol 400 5% / Heparinoid 0.2% rectal ointment
0107010J0AAABAB
Lauromacrogol/ Heparinoid Heparinoid Gastro-Intestinal System No data available
Lauromacrogol 400 50mg / Heparinoid 4mg suppositories
0107010J0AAAAAA
Lauromacrogol/ Heparinoid Heparinoid Gastro-Intestinal System No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.